Conflict of interest declaration: Ernest HS Choy

Roles in: Musculoskeletal Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
Yes - Professor Ernest Choy has served as member of speaker bureaus of Amgen, BMS, Chugai Pharma, Eli Lilly, Pfizer, Regeneron, Roche, Sanofi, and UCB.

c) Fees for organising education?
Yes - Benecke

d) Funds for research?
Yes - Professor Ernest Choy has received research grants from Bio-Cancer, Biogen, Novartis, Pfizer, Roche, Sanofi and UCB.

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - Professor Ernest Choy has served as consultant for Abbvie, Amgen, Biogen, Celgene, Chugai Pharma, Eli Lilly, Gilead, Hospira, Janssen, Napp, Novartis, ObsEva, Novimmune, Pfizer, Regeneron, Roche, R-Pharm, SynAct Pharma, Sanofi-Genzyme and Tonix.

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
No